The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

Erol ErduranDepartment of Pediatric Hematology, Karadeniz Technical University, School of Medicine, Trabzon, TurkeyCorrespondence[email protected]

Aysenur BahadirDepartment of Pediatric Hematology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey

REFERENCES

Thorp JA, O'Connor T, Callenbach GR, Hypogenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol. 1991;165:79–81.
PubMedGoogle Scholar
Koenig JM, Asthon DR, De Vore GS, Late hypogenerative anemia in Rh hemolytic disease. J Pediatr. 1989;115:315–318.
PubMed Web of Science ®Google Scholar
Zuppa AA, Maragliano G, Scapillati ME, Recombinant erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-haemolytic disease. Fetal Diagn Ther. 1999;14:270–274.
PubMedGoogle Scholar
Lasker MR, Eddleman K, Toor AH. Neonatal hepatitis and excessive hepatic iron deposition following intrauterin blood transfusion. Am J Perinatol. 1995;12:14–17.
PubMedGoogle Scholar
Zuppa AA, Alighieri G, Calabrese, Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization. J Pediatr Hematol Oncol. 2010;32:e95–e101.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date